The latest medical insurance prices of Jisandai (Bingtonsha) in 2024

Epclusa is a drug used to treat chronic hepatitis C. Chronic hepatitis C is a liver disease caused by the hepatitis C virus (HCV) and, if left untreated, can lead to serious health problems such as cirrhosis and liver cancer.

Jisandai (Bingtonsha) has been officially launched in the country and has been included in the medical insurance system. Therefore, patients can purchase it directly in the country, and the price remains within the range of two to three thousand yuan. For specific costs and medical insurance reimbursement details, it is recommended that you consult your local hospital or pharmacy for detailed consultation. In addition, if you are looking for a more economical option, you can consider the generic drugs of Gensida (Bintongsa) . The prices of the Bangladeshi and Indian versions of the generic drugs are relatively affordable, ranging from a few hundred to more than a thousand yuan, and their pharmaceutical ingredients are basically the same as the domestic original drugs.

Gilead Sciences is an oral drug developed and produced by Gilead Sciences , an American pharmaceutical company. It is a direct antiviral drug (DAAs) that treats hepatitis C by inhibiting viral replication. Gisanda (Bingtonsa) is a compound drug containing two active ingredients: sofosbuvir (sofosbuvir) and velpatasvir (velpatasvir). Sofosbuvir is a nucleoside reverse transcriptase inhibitor, while vilbiravir is an NS5A inhibitor. Their combination makes Jisandai (Bingtonsha) possess broad-spectrum antiviral activity and can act on different parts of the hepatitis C virus at the same time to improve the therapeutic effect.

The treatment plan for Jisandai (Bingtonsha) is usually one pill taken once a day, and the treatment cycle is generally 12 weeks. Compared with traditional treatment options such as interferon and ribavirin, Gsanda (Bingtonsa) has a higher cure rate and fewer side effects. Its efficacy has been well established in clinical trials and has been shown to be effective against multiple HCV genotypes.

UsageJisandai (Bingtonsha) Patients treating chronic hepatitis C should follow the doctor's instructions, take the drug on time and in the right amount, and have regular reviews to monitor the efficacy and possible side effects. AlthoughJi Sandai (Bingtongsha)It is considered a relatively safe and effective drug, but some adverse reactions may still occur during use, such as headache, fatigue, nausea, diarrhea, etc. Therefore, patients need to pay close attention to their physical condition and report any abnormal reactions to their doctor in a timely manner.